Form 4 for CLDX Celldex Therapeutics, Inc.
Accepted 2024-06-13 00:00:00 ET · period of report 2024-06-11 · accession 0001415889-24-016651 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-13 | 2024-06-11 | CLDX | Young Diane C. | SVP, Chief MEDICAL Off | M - OptEx | $2.71 | +15.0K | 17.1K | +709% | +$40.6K |
| D | 2024-06-13 | 2024-06-11 | CLDX | Young Diane C. | SVP, Chief MEDICAL Off | M - OptEx | $0.00 | -15.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-11 | M | A | 15,000 | $2.71 | 17,115 | D | — | — | |
| 2 | Derivative | Incentive Stock Option | 2024-06-11 | M | D | 15,000 | $0.00 | 0 | D | $2.71 · — to 2029-07-08 | 15,000 Common Stock | (F1) As of July 8, 2023, the option is fully vested. |